Where does Revivo Medical, Llc rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Revivo Medical, Llc ranks #21,690 of 50,000 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Revivo Medical, Llc hold?

Revivo Medical, Llc holds 13 US utility patents granted between 2016 and 2024, spanning 2 technology areas.

What is Revivo Medical, Llc's Innovation Score?

Revivo Medical, Llc has an Innovation Score of 28.0 out of 100 (top 74% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Revivo Medical, Llc's patent grant rate increasing or decreasing?

Revivo Medical, Llc's recent grant velocity is -14% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Revivo Medical, Llc's patents?

Revivo Medical, Llc's patents average 19.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Revivo Medical, Llc patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Revivo Medical, Llc

Q: What technology areas does Revivo Medical, Llc focus on?

Revivo Medical, Llc's top technology area is A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS) with 10 patents. Grants appear in 2 CPC subclasses total.

USPTO PatentsView assignee record - 13 granted patents across 2 technology areas, recorded in grant years 2016–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE).

Compiled by PlainPatent · May 15, 2026

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Revivo ranks #21,690 of 50,000 tracked US assignees by granted-patent volume, with 13 patents across 2 technology areas.

#21,690
of 50,000 US assignees by volume: Top 74%
by Innovation Score (28.0/100): 19.4
avg claims per patent: -14%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R21690 · US Corporation #21,690 · 13 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL

GRANTS-MICRO 13 grants
MID-PACK #21,690/50,000
PHOTO-FINISH RENISHAW (IRELAND)
CPC-NARROW A61F · 2 areas
INNOV-THIN 28.0/100
CLAIMS-RICH 19.4 claims/avg
TYPE-USCORP US Corporation
VEL-DOWN -14% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Renishaw (ireland) Limited (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Revivo Medical · this assignee

28
3D Lighting Innovati… · lowest

7

What this shows Revivo's Innovation Score is 28.0/100 (top 74% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Revivo's grants concentrate

Revivo Medical, Llc is a focused PatentsView assignee: 2 CPC subclasses with 76.9% of grants classified under A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE). Peak complete grant year is 2020 (3 grants) versus a trough of 1 in 2016. By volume, Revivo sits between Renishaw (ireland) Limited and RIPD IP Development Ltd.

Renishaw (Ireland)

13
Reprieve Cardiova…

13
Restek

13
Reviva Pharmaceut…

13
Reyco Granning

13
Rf360 Europe

13
Rhodia Poliamida…

13
RIPD IP Developme…

13
Revivo Medical ◀

13

What this shows Revivo holds 13 patents at rank #21,668, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Revivo

By rank, the assignees closest to #21,668 in granted patent volume.

Leaders in A61F (Filters Implantable INTO Blood Vessels)

Other assignees with the most granted patents in Revivo's primary technology class.

Revivo's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

28 Top 74% higher than 26% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Revivo Medical, Llc patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	7.7%
2017	2	15.4%
2018	2	15.4%
2019	2	15.4%
2020	3	23.1%
2021	1	7.7%
2022	1	7.7%
2024	1	7.7%

Which technologies does Revivo Medical, Llc patent most?

A61F - FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS 10

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 7

Top 2 of 2 technology areas

Where it ranks

Overall rank by patents

#21,690

of 50,000 tracked assignees

Innovation Score

28.0 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.